Related Experiment Video
Updated: Jul 28, 2026
10:32
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
Changes in cortical functioning with acute hypoglycemia and hyperglycemia in type I diabetes
R G Hoffman1, D J Speelman, D A Hinnen
1Department of Behavioral Sciences, University of Minnesota, School of Medicine, Duluth, Minnesota 55812.
Diabetes Care
|March 1, 1989
Summary
Hypoglycemia significantly impairs cognitive and psychomotor functions in type I diabetes patients. Tasks involving visual tracking, speed, concentration, and planning were most affected, while reaction time remained stable.
Area of Science:
- Endocrinology
- Neuroscience
- Metabolic Disorders
Background:
- Type I diabetes (insulin-dependent diabetes) affects glucose regulation.
- Cognitive and psychomotor functions may be sensitive to blood glucose fluctuations.
Purpose of the Study:
- To investigate the impact of varying blood glucose levels (hypoglycemia, normoglycemia, hyperglycemia) on cognitive and psychomotor performance in type I diabetes patients.
Main Methods:
- 18 type I diabetes patients (aged 22-35) underwent cognitive and psychomotor testing.
- Blood glucose levels were precisely controlled at 50 mg/dl (hypoglycemia), 100 mg/dl (normoglycemia), and 300 mg/dl (hyperglycemia) using a Biostator system.
- A single-blinded, counterbalanced design was employed.
Main Results:
- Performance on visual tracking, visuomotor speed, concentration, and planning tasks (pursuit rotor, trails B) was significantly impaired during hypoglycemia compared to normoglycemia.
- Visual reaction time was not significantly affected by either hypoglycemia or hyperglycemia.
Conclusions:
- Hypoglycemia adversely affects specific cognitive and psychomotor abilities in individuals with type I diabetes.
- Maintaining stable blood glucose levels is crucial for optimal cognitive and psychomotor function in diabetic patients.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...